BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dębska-Zielkowska J, Moszkowska G, Zieliński M, Zielińska H, Dukat-Mazurek A, Trzonkowski P, Stefańska K. KIR Receptors as Key Regulators of NK Cells Activity in Health and Disease. Cells 2021;10:1777. [PMID: 34359951 DOI: 10.3390/cells10071777] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Alexandrova M, Manchorova D, Dimova T. Immunity at maternal-fetal interface: KIR/HLA (Allo)recognition. Immunol Rev 2022. [PMID: 35610960 DOI: 10.1111/imr.13087] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Casado JL, Moraga E, Vizcarra P, Velasco H, Martín-Hondarza A, Haemmerle J, Gómez S, Quereda C, Vallejo A. Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients. Viruses 2021;14:46. [PMID: 35062250 DOI: 10.3390/v14010046] [Reference Citation Analysis]
3 Pu Q, Cao X, Liu Y, Yan D, Tan R, Li J, Yue B. Comprehensive Analysis and Summary of the Value of Immunophenotypes of Mature NK Cell Tumors for Differential Diagnosis, Treatment, and Prognosis. Front Immunol 2022;13:918487. [DOI: 10.3389/fimmu.2022.918487] [Reference Citation Analysis]
4 De Sanctis JB, Garmendia JV, Hajdúch M. Overview of Memory NK Cells in Viral Infections: Possible Role in SARS-CoV-2 Infection. Immuno 2022;2:52-67. [DOI: 10.3390/immuno2010005] [Reference Citation Analysis]
5 Kusowska A, Kubacz M, Krawczyk M, Slusarczyk A, Winiarska M, Bobrowicz M. Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma. Int J Mol Sci 2022;23:1501. [PMID: 35163421 DOI: 10.3390/ijms23031501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Robertson SA, Moldenhauer LM, Green ES, Care AS, Hull ML. Immune determinants of endometrial receptivity: a biological perspective. Fertil Steril 2022;117:1107-20. [PMID: 35618356 DOI: 10.1016/j.fertnstert.2022.04.023] [Reference Citation Analysis]
7 Muraro E, De Zorzi M, Miolo G, Lombardi D, Scalone S, Spazzapan S, Massarut S, Perin T, Dolcetti R, Steffan A, De Re V. KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer. Front Immunol 2021;12:791958. [PMID: 35095867 DOI: 10.3389/fimmu.2021.791958] [Reference Citation Analysis]
8 Hellesen A, Aslaksen S, Breivik L, Røyrvik EC, Bruserud Ø, Edvardsen K, Brokstad KA, Wolff ASB, Husebye ES, Bratland E. 21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison's Disease Are Restricted by HLA-A2 and HLA-C7 Molecules. Front Immunol 2021;12:742848. [PMID: 34721410 DOI: 10.3389/fimmu.2021.742848] [Reference Citation Analysis]